Guest Column: Manufacturers, Suppliers Offer Perspectives On Supplier Quality Program
This article was originally published in The Gray Sheet
More than 30 companies now participate in the device industry-managed supply chain oversight program MedAccred. “Ultimately, the goal is to achieve a consistently high level of product quality from our special process vendors," Stryker's Bruce Dall explains.
You may also be interested in...
Patent litigation settlements have paved the way for Endo’s Par and Teva to secure the first US approvals for generic versions of Novartis’ Afinitor everolimus brand.
Amneal has become the first company to secure US approval for, and to launch, a generic alternative to Merck & Co’s top-selling, off-patent NuvaRing contraceptive device in the US. Other generics developers appear to be several months behind.